Analyze Diet
Drug testing and analysis2012; 5(5); 306-314; doi: 10.1002/dta.1329

Detection of fluticasone propionate in horse plasma and urine following inhaled administration.

Abstract: Fluticasone propionate (FP) is an anti-inflammatory agent with topical and inhaled applications commonly used in the treatment of asthma in steroid-dependent individuals. The drug is used in racehorses to treat Inflammatory Airway Disease; this work was performed in order to advise on its use and detect potential misuse close to racing. Methods were developed for the extraction and analysis of FP from horse plasma and a carboxylic acid metabolite (FP-17βCOOH) from horse urine. The methods utilize ultra high performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) in order to detect the extremely low concentrations of analyte present in both matrices. The developed methods were used to analyse plasma and urine samples collected following inhaled administration of FP to six thoroughbred horses. FP was detected in plasma for a minimum of 72 h post-administration and FP-17βCOOH was detected in urine for approximately 18 h post-administration. The results show that it is possible to detect FP in the horse following inhaled administration.
Publication Date: 2012-04-18 PubMed ID: 22514113DOI: 10.1002/dta.1329Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study focuses on detecting the presence of the anti-inflammatory drug fluticasone propionate (FP) in horse plasma and urine. Through the development of specific analysis methods, FP was detected in plasma for at least 72 hours after being administered in inhalation form to racehorses and in urine for about 18 hours after administration.

Overview of Research

  • The research aims to devise a means to assess the presence and duration of FP in horse plasma and urine, following topical and inhaled application for managing Inflammatory Airway Disease in racehorses.
  • The need to track FP incidence comes from its propensity to be misused in the racing industry, reinforcing the importance of this study.

Methods Development

  • To extract and analyze FP from horse plasma – and FP’s byproduct, FP-17βCOOH, from horse urine – the researchers developed specific methods.
  • Ultra-high-performance liquid chromatography (UPLC-MS/MS) was used to detect the extremely low concentrations of analytes present in both the blood and urine of horses.

Experiment Procedure

  • After formulating the extraction and analysis methods, the researchers tested their application by administering FP to six thoroughbred horses via inhalation.
  • They then collected and analyzed plasma and urine samples from the subjects.

Results

  • The results confirmed that the methods developed were effective: FP was detected in plasma for at least 72 hours following administration and FP-17βCOOH was detected in urine for approximately 18 hours thereafter.
  • This suggests that the defined techniques can provide a reliable means of detecting FP misuse, given its prolonged detectability post-administration.

Significance

  • The successful detection of FP in horse plasma and urine represents a significant step in controlling its potential misuse in racehorse treatment.
  • With these methods, regulatory bodies can identify potential misuse and enforce measures to maintain fair competition, supporting the integrity and welfare of the animals.

Cite This Article

APA
Gray BP, Biddle S, Pearce CM, Hillyer L. (2012). Detection of fluticasone propionate in horse plasma and urine following inhaled administration. Drug Test Anal, 5(5), 306-314. https://doi.org/10.1002/dta.1329

Publication

ISSN: 1942-7611
NlmUniqueID: 101483449
Country: England
Language: English
Volume: 5
Issue: 5
Pages: 306-314

Researcher Affiliations

Gray, Bobby P
  • HFL Sport Science, Fordham, Cambridgeshire, UK. bgray@hfl.co.uk
Biddle, Simon
    Pearce, Clive M
      Hillyer, Lynn

        MeSH Terms

        • Administration, Inhalation
        • Androstadienes / administration & dosage
        • Androstadienes / blood
        • Androstadienes / metabolism
        • Androstadienes / urine
        • Animals
        • Anti-Inflammatory Agents / administration & dosage
        • Anti-Inflammatory Agents / blood
        • Anti-Inflammatory Agents / metabolism
        • Anti-Inflammatory Agents / urine
        • Chromatography, High Pressure Liquid
        • Fluticasone
        • Horses / blood
        • Horses / urine
        • Tandem Mass Spectrometry

        Citations

        This article has been cited 3 times.
        1. Mahalingam-Dhingra A, Mazan MR, Bedenice D, Ceresia M, Minuto J, Deveney EF. A CONSORT-guided, randomized, double-blind, controlled pilot clinical trial of inhaled lidocaine for the treatment of equine asthma. Can J Vet Res 2022 Apr;86(2):116-124.
          pubmed: 35388235
        2. Mainguy-Seers S, Lavoie JP. Glucocorticoid treatment in horses with asthma: A narrative review. J Vet Intern Med 2021 Jul;35(4):2045-2057.
          doi: 10.1111/jvim.16189pubmed: 34085342google scholar: lookup
        3. Couëtil LL, Cardwell JM, Gerber V, Lavoie JP, Léguillette R, Richard EA. Inflammatory Airway Disease of Horses--Revised Consensus Statement. J Vet Intern Med 2016 Mar-Apr;30(2):503-15.
          doi: 10.1111/jvim.13824pubmed: 26806374google scholar: lookup